VEGF165, Bcl-2, p53, COX-2 and HER-family expression in patients with stage IB-IIIA completely resected non-small cell lung cancer (NSCLC) and correlation with clinical outcome.

被引：0
|
作者：
Timotheadou, E
Murray, S
Linardou, H
Vrettou, AV
Skrickova, J
Kosmidis, P
Skarlos, DV
Pectasides, D
Fountzilas, G
机构：
[1] Papageorgiou Hosp, Dept Med Oncol, Thessaloniki, Greece
[2] Mol Biol & Genet Metropolitan Hosp, Athens, Greece
[3] Metropolitan Hosp, Dept Oncol, Athens, Greece
[4] Univ Hosp Brno, Brno, Czech Republic
[5] HYGEIA Hosp, Oncol Pathol Clin 2, Athens, Greece
[6] Errikos Dunant Hosp, B Oncol Dept, Athens, Greece
[7] Univ Athens, Attikon Hosp, Athens, Greece
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：681S / 681S
页数：1
相关论文
共 50 条
  • [1] Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small cell lung cancer
    Borner, MM
    Brousset, P
    Pfanner-Meyer, B
    Bacchi, M
    Vonlanthen, S
    Hotz, MA
    Altermatt, HJ
    Schlaifer, D
    Reed, JC
    Betticher, DC
    BRITISH JOURNAL OF CANCER, 1999, 79 (5-6) : 952 - 958
  • [2] Prognostic evaluation of the expression of p53 and bcl-2 oncoproteins in patients with surgically resected non-small cell lung cancer
    Lai, RS
    Wang, JS
    Hsu, HK
    Chang, HC
    Lin, CH
    Lin, MH
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2002, 32 (10) : 393 - 397
  • [3] Apoptosis bcl-2 and p53 expression and their relation to tumour stage in non-small cell lung carcinomas (NSCLC)
    Kargi, HA
    Aktas, S
    Sagol, O
    Ermete, S
    Akpinar, O
    Akkoclu, A
    CANCER LETTERS, 1997, 116 (02) : 185 - 189
  • [4] The expression of p53 and bcl-2 in stage III non-small cell lung carcinoma (NSCLC) treated with radiotherapy
    Langendijk, JA
    Thunnissen, FBJM
    Arends, JW
    de Jong, JMA
    ten Velde, GPM
    Lamers, RJS
    Wouters, EFM
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A712 - A712
  • [5] Expression of bcl-2, p53 and VEGF in non-small cell lung cancer: Their relation with microvascular density and prognosis
    Yoo, J
    Kim, S
    Shim, B
    Jo, M
    Song, S
    Cho, D
    Ahn, M
    Kim, C
    Cho, K
    Kim, H
    LUNG CANCER, 2005, 49 : S299 - S299
  • [6] The clinical relevance of Bcl-2, Rb and p53 expression in advanced non-small cell lung cancer
    Gregorc, V
    Darwish, S
    Ludovini, V
    Pistola, L
    De Angelis, V
    Mihaylova, Z
    Bellezza, G
    Sidoni, A
    Cavaliere, A
    Bucciarelli, E
    Massaro, G
    Tonato, M
    LUNG CANCER, 2003, 42 (03) : 275 - 281
  • [7] Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer
    M M Borner
    P Brousset
    B Pfanner-Meyer
    M Bacchi
    S Vonlanthen
    M A Hotz
    H J Altermatt
    D Schlaifer
    J C Reed
    D C Betticher
    British Journal of Cancer, 1999, 79 : 952 - 958
  • [8] Expression of p21 and bcl-2 proteins and p53 mRNA in surgically resected preparations of non-small cell lung cancer (stage IIIA) after etoposide and cisplatin chemotherapy
    Mandziuk, S
    Dudzisz-Sledz, M
    Rybacka-Chabros, B
    Zdunek, M
    Jakubowicz-Klecha, A
    Korobowicz, E
    Milanowski, J
    Wojcierowski, J
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2001, 39 : 175 - 176
  • [9] The interactive effect of Ras, HER2, P53 and Bcl-2 expression in predicting the survival of non-small cell lung cancer patients
    Kim, YC
    Park, KO
    Kern, JA
    Park, CS
    Lim, SC
    Jang, AS
    Yang, JB
    LUNG CANCER, 1998, 22 (03) : 181 - 190
  • [10] bcl-2 and p53 protein expression in non-small cell lung cancers: Correlation with survival time
    Ohsaki, Y
    Toyoshima, E
    Fujiuchi, S
    Matsui, H
    Hirata, S
    Miyokawa, N
    Kubo, Y
    Kikuchi, K
    CLINICAL CANCER RESEARCH, 1996, 2 (05) : 915 - 920
12345